The role of small-intestinal P450 enzymes in protection against systemic exposure of orally administered benzo[a]pyrene

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 1, 2010, Pages 156-163

  Fang, Cheng ^a   Zhang, Qing Yu ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; BETA NAPHTHOFLAVONE; CYTOCHROME P450 1A1; CYTOCHROME P450 REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; FIRST PASS EFFECT; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE;

ADMINISTRATION, ORAL; ANIMALS; BENZO(A)PYRENE; INTESTINAL MUCOSA; INTESTINE, SMALL; KIDNEY; LIVER; LUNG; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSOMES; NADPH-FERRIHEMOPROTEIN REDUCTASE; TISSUE DISTRIBUTION;

EID: 77953765707     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.167742     Document Type: Article

References (28)

1. Arlt VM, Stiborová M, Henderson CJ, Thiemann M, Frei E, Aimová D, Singh R, Gamboa da Costa G, Schmitz OJ, Farmer PB, et al. (2008) Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice. Carcinogenesis 29:656-665.
2. Bellier S, Da Silva NR, Aubin-Houzelstein G, Elbaz C, Vanderwinden JM, and Panthier JJ (2005) Accelerated intestinal transit in inbred mice with an increased number of interstitial cells of Cajal. Am J Physiol Gastrointest Liver Physiol 288:G151-G158.
3. Brauze D, Mikstacka R, and Baer-Dubowska W (1991) Formation and persistence of benzo[a]pyrene-DNA adducts in different tissues of C57BL/10 and DBA/2 mice. Carcinogenesis 12:1607-1611.
4. Brooks RA, Gooderham NJ, Edwards RJ, Boobis AR, and Winton DJ (1999) The mutagenicity of benzo[a]pyrene in mouse small intestine. Carcinogenesis 20:109-114.
5. Charman WN, Porter CJ, Mithani S, and Dressman JB (1997) Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 86:269-282.
6. Culp SJ, Warbritton AR, Smith BA, Li EE, and Beland FA (2000) DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene. Carcinogenesis 21:1433-1440.
7. Denissenko MF, Pao A, Tang M, and Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274: 430-432.
8. DeSesso JM and Jacobson CF (2001) Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol 39:209-228.
9. Fang C, Behr M, Xie F, Lu S, Doret M, Luo H, Yang W, Aldous K, Ding X, and Gu J (2008a) Mechanism of chloroform-induced renal toxicity: non-involvement of hepatic cytochrome P450-dependent metabolism. Toxicol Appl Pharmacol 227: 48-55.
10. Fang C, Gu J, Xie F, Behr M, Yang W, Abel ED, and Ding X (2008b) Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity. Drug Metab Dispos 36:1722-1728.
11. Galván N, Teske DE, Zhou G, Moorthy B, MacWilliams PS, Czuprynski CJ, and Jefcoate CR (2005) Induction of CYP1A1 and CYP1B1 in liver and lung by benzo-(a)pyrene and 7,12-d imethylbenz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity. Toxicol Appl Pharmacol 202:244-257.
12. Gu J, Weng Y, Zhang QY, Cui H, Behr M, Wu L, Yang W, Zhang L, and Ding X (2003) Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem 278:25895-25901.
13. Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, and Wolf CR (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J Biol Chem 278:13480-13486.
14. Kaminsky LS and Fasco MJ (1991) Small intestinal cytochromes P450. Crit Rev Toxicol 21:407-422.
15. Nebert DW and Gelboin HV (1968) Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J Biol Chem 243:6242-6249.
16. Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, and Zeldin DC (2006) The human intestinal cytochrome P450 "pie". Drug Metab Dispos 34:880-886.
17. Phillips DH (1999) Polycyclic aromatic hydrocarbons in the diet. Mutat Res 443:139-147.
18. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y, and Ishikawa T (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 97:779-782.
19. Sinha R, Kulldorff M, Gunter MJ, Strickland P, and Rothman N (2005) Dietary benzo[a]pyrene intake and risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 14:2030-2034. (Pubitemid 41161219)
20. Uno S, Dalton TP, Derkenne S, Curran CP, Miller ML, Shertzer HG, and Nebert DW (2004) Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol 65:1225-1237.
21. Uno S, Dalton TP, Dragin N, Curran CP, Derkenne S, Miller ML, Shertzer HG, Gonzalez FJ, and Nebert DW (2006) Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol Pharmacol 69:1103-1114.
22. Uno S, Dragin N, Miller ML, Dalton TP, Gonzalez FJ, and Nebert DW (2008) Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. Free Radic Biol Med 44:570-583.
23. van Herwaarden AE, Wagenaar E, van der Kruijssen CM, van Waterschoot RA, Smit JW, Song JY, van der Valk MA, van Tellingen O, van der Hoorn JW, Rosing H, et al. (2007) Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. J Clin Invest 117:3583-3592.
24. Weng Y, Fang C, Turesky RJ, Behr M, Kaminsky LS, and Ding X (2007) Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice. Cancer Res 67:7825-7832.
25. Zhang QY, Dunbar D, and Kaminsky LS (2003) Characterization of mouse small intestinal cytochrome P450 expression. Drug Metab Dispos 31:1346-1351.
26. Zhang QY, Dunbar D, Ostrowska A, Zeisloft S, Yang J, and Kaminsky LS (1999) Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos 27:804-809. (Pubitemid 29297778)
27. Zhang QY, Fang C, Zhang J, Dunbar D, Kaminsky L, and Ding X (2009) An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal P450s in first-pass clearance of oral nifedipine. Drug Metab Dispos 37:651-657.
28. Zhang QY, Kaminsky LS, Dunbar D, Zhang J, and Ding X (2007) Role of small intestinal cytochromes P450 in the bioavailability of oral nifedipine. Drug Metab Dispos 35:1617-1623.